News

A look at what patient centricity in clinical research means and how it has evolved.

Insights from ExL’s 5th Clinical Trials Phase I & Phase IIA Summit on early phase trials.

The FDA planned budget features added funds allotted to improved oversight of drugs, biologics, and medical devices.

What started as an initiative called Risk-Based Monitoring several years ago is now evolving into Risk-Based Quality Management of clinical trials with a much wider impact to the pharma industry.

Gottlieb’s tenure included record new drug approvals and steps taken to curb opioid abuse.

Examining the implications of shipping temperature-sensitive clinical supplies in an evolving clinical supply chain, including shipments direct to patient homes (DTP) and the need for temperature monitoring thereof.

Recent initiatives demonstrate that European health authorities are serious about combatting the proliferation of threats and opportunities from big data.